Zorgstandaard Neurofibromatose type-2

94 / 106

94
Schaedle, and M. Giovannini, “Consensus recommendations for current treatments and accelerating
clinical trials for patients with neurofibromatosis type 2,” Am J Med Genet A, 2011.
[99]A. K. LUMC, “Patiëntenfolder Brughoektumor’’.” Nov-2011.
[100] A. Balasubramaniam, P. Shannon, M. Hodaie, N. Laperriere, H. Michaels, and A. Guha, “Glioblastoma
multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the
literature,” Neuro-Oncol., vol. 9, no. 4, pp. 447–453, Oct. 2007.
[101] Y. Kida, T. Kobayashi, T. Tanaka, and Y. Mori, “Radiosurgery for bilateral neurinomas associated with
neurofibromatosis type 2,” Surg. Neurol., vol. 53, no. 4, pp. 383–389; discussion 389–390, Apr. 2000.
[102] S. Safavi-Abbasi, N. C. Bambakidis, J. M. Zabramski, R. Workman, K. Verma, M. Senoglu, R. W. Porter,
and R. F. Spetzler, “Nonvestibular schwannomas: an evaluation of functional outcome after radiosurgical
and microsurgical management,” Acta Neurochir. (Wien), vol. 152, no. 1, pp. 35–46, Jan. 2010.
[103] P. V. Ter Wengel, J. C. Reijneveld, F. J. Lagerwaard, and S. Peerdeman, “Meningeomen, deel I:
biologisch gedrag en behandelstrategieën,” Tijdschr Neurol Neurochir, vol. 111, pp. 200–209, 2010.
[104] R. Aboukais, F. Zairi, M. Baroncini, N.-X. Bonne, S. Schapira, C. Vincent, and J.-P. Lejeune,
“Intracranial meningiomas and neurofibromatosis type 2,” Acta Neurochir. (Wien), vol. 155, no. 6, pp.
997–1001; discussion 1001, Jun. 2013.
[105] A. T. M. Rennie, L. Side, R. S. C. Kerr, P. Anslow, and P. Pretorius, “Intramedullary tumours in patients
with neurofibromatosis type 2: MRI features associated with a favourable prognosis,” Clin. Radiol., vol.
63, no. 2, pp. 193–200, Feb. 2008.
[106] P. L. Zadnik, Z. L. Gokaslan, P. C. Burger, and C. Bettegowda, “Spinal cord tumours: advances in
genetics and their implications for treatment,” Nat. Rev. Neurol., vol. 9, no. 5, pp. 257–266, May 2013.
[107] K. J. Minehan, P. D. Brown, B. W. Scheithauer, W. E. Krauss, and M. P. Wright, “Prognosis and
treatment of spinal cord astrocytoma,” Int J Radiat Oncol Biol Phys, vol. 73, no. 3, pp. 727–33, 2009.
[108] Nederlandse Vereniging voor Neurologie en Nederlandse Vereniging voor Klinische Neurofysiologie,
“Richtlijn Polyneuropathie.” 2005.
[109] Nederlands Oogheelkundig Gezelschap, “Richtlijn cataract,” Nijmegen, 2013.
[110] M. V. Gossman, “Papilledema,” Medscape , 19-Mar-2013. [Online]. Available:
[Accessed: 02-Dec-2013].
[111] Nederlandse Vereniging voor Dermatologie en Venereologie, “Richtlijn Laserbehandeling en
flitslamptherapie.” 2004.
[112] S. Prabhakar, S. M. Messerli, A. O. Stemmer-Rachamimov, T.-C. Liu, S. Rabkin, R. Martuza, and X. O.
Breakefield, “Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex
virus G47Delta,” Cancer Gene Ther., vol. 14, no. 5, pp. 460–467, May 2007.
[113] M. Khodaee, “Painless cutaneous nodules,” J. Fam. Pract., vol. 61, no. 8, pp. 489–491, Aug. 2012.
[114] L. K. Kriechbaumer, M. Susani, S. G. Kircher, and W. Happak, “Vaporization of cutaneous
neurofibromas with an erbium: yttrium-aluminum-garnet laser: a comparative histologic evaluation,”
Plast. Reconstr. Surg., vol. 129, no. 3, p. 602e–604e, Mar. 2012.
[115] C. M. Patel, R. Ferner, and E. A. Grunfeld, “A qualitative study of the impact of living with
neurofibromatosis type 2,” Psychol Health Med, vol. 16, no. 1, pp. 19–28.
[116] Academisch Ziekenhuis Maastricht, “Cochleaire Implantatie.” Jun-2011.
[117] VUMC, “Operatie en verblijf in het ziekenhuis,” 12-Jun-2013. [Online]. Available: -
[118] Stiching Plotsdoven, “Wat is een Cochleair Implantaat (CI)?,” 12-Jun-2013. [Online]. Available:
[119] De oorgroep, “Hersenstam implantatie: de ingreep,” 12-Jun-2013. [Online]. Available:
.
[120] M. Sanna, F. Di Lella, M. Guida, and P. Merkus, “Auditory brainstem implants in NF2 patients: results
and review of the literature,” Otol. Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol.
Neurotol., vol. 33, no. 2, pp. 154–164, Feb. 2012.